Screener
IDEAYA Biosciences, Inc. IDYA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (108,544) | (84,389) |
| Other income | ||
| Interest income and other income, net | 10,005 | 12,211 |
| Net loss | $(98,539) | $(72,178) |
| Unrealized (losses) gains on marketable securities | (2,761) | 773 |
| Comprehensive loss | $(101,300) | $(71,405) |
| Net loss per common share, basic and diluted | $(1.11) | $(0.82) |
| Weighted-average common shares outstanding, basic and diluted | 88,699,754 | 88,356,335 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s EPS (diluted)?
- IDEAYA Biosciences, Inc. (IDYA) reported EPS (diluted) of -$1.11 in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s EPS (diluted) changed year-over-year?
- IDEAYA Biosciences, Inc.'s EPS (diluted) decreased by 35.4% year-over-year, from -$0.82 to -$1.11.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s EPS (diluted) has grown at a -1.8% compound annual growth rate (CAGR), from -$1.41 to -$1.31.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about IDEAYA Biosciences, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude